TrialThe international journal of neuropsychopharmacology2024

Therapeutic Effect of Evenamide, a Glutamate Inhibitor, in Patients With Treatment-Resistant Schizophrenia (TRS): Final, 1-Year Results From a Phase 2, Open-Label, Rater-Blinded, Randomized, International Clinical Trial.

Ravi Anand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.